Acetaminophen Market Players:
- Sanofi
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott
- Lupin
- Pfizer
- Aurobindo
- Sun Pharma
- Dr. Reddy’s Laboratories
- Novartis
- Teva Pharmaceuticals
- Bayer
Companies globally suppliers work round the clock to meet the never-ending demand for acetaminophen alone, and in combination with other drugs, to quickly alleviate any discomfort.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of acetaminophen is assessed at USD 11.26 billion.
The global acetaminophen market size surpassed USD 10.85 billion in 2025 and is projected to grow at a CAGR of more than 4.2%, reaching USD 16.37 billion revenue by 2035.
North America acetaminophen market will hold more than 37% share by 2035, driven by robust healthcare infrastructure and rising demand due to chronic pain and illnesses.
Key players in the market include Mallinckrodt Pharmaceuticals, Johnson & Johnson, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V. (Viatris), Perrigo Company plc, Zydus Cadila, Aurobindo Pharma Limited.
